MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma

Molecular Cancer Research

Volumn 11, Issue 2, 2013, Pages 161-172

  Castro, Ines C ^a   Breiling, Achim ^b   Luetkenhaus, Katharina ^a   Ceteci, Fatih ^e   Hausmann, Simone ^c   Kress, Sebastian ^a   Lyko, Frank ^b   Rudel, Thomas ^a   Rapp, Ulf R ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^e BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; TRANSCRIPTION FACTOR GATA 4; ZINC FINGER PROTEIN;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; EPIGENETICS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; LUNG NEOPLASMS; MALE; MUCIN-2; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RAS PROTEINS; TRANSCRIPTION FACTORS;

EID: 84874419331     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0414-T     Document Type: Article

References (35)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
2. Rapp UR, Ceteci F, Schreck R. Oncogene-induced plasticity and cancer stem cells. Cell Cycle 2008;7:45-51.
3. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008;123:1-7.
4. Rapp UR, Korn C, Ceteci F, Karreman C, Luetkenhaus K, Serafin V, et al. Myc is a metastasis gene for non-small-cell lung cancer. PLoS ONE 2009;4:e6029.
5. Rapp UR. Metastasis as a faulty recapitulation of ontogeny. Nature Precedings 2007;258:83-136
6. Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, et al. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene 1988; 2:607-11.
7. Lowry JA, Atchley WR. Molecular evolution of the GATA family of transcription factors: Conservation within the DNA-binding domain. J Mol Evol 2000;50:103-15.
8. Liu C, Glasser SW, Wan H, Whitsett JA. GATA-6 and thyroid transcription factor-1 directly interact and regulate surfactant protein-C gene expression. J Biol Chem 2002;277:4519-25.
9. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet 2008;40:862-70.
10. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995;23:1686-90.
11. Fang R, Olds LC, Santiago NA, Sibley E. GATA family transcription factors activate lactase gene promoter in intestinal Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2001;280:G58-67.
12. Musch T, Oz Y, Lyko F, Breiling A. Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors. PLoS ONE 2010;5:e10726.
13. van der Sluis M, Melis MHM, Jonckheere N, Ducourouble M-P, Buller HA, Renes I, et al. The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells. Biochem. Biophys Res Commun 2004;325:952-60.
14. Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 2009;28:2796-805.
15. Werner T. Computer-assisted analysis of transcription control regions. Matinspector and other programs. Methods Mol Biol 2000;132: 337-49.
16. Song J, Ugai H, Kanazawa I, Sun K, Yokoyama KK. Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements. J Biol Chem 2001;276:19897-904.
17. Kyronlahti A, Ramo M, Tamminen M, Unkila-Kallio L, Butzow R, Leminen A, et al. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors. Endocrinology 2008;149:5635-42.
18. Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer 2010;1:1178-88.
19. Anttonen M, Unkila-Kallio L, Leminen A, Butzow R, Heikinheimo M. High GATA-4 expression associates with aggressive behavior, whereas low anti-Mullerian hormone expression associates with growth potential of ovarian granulosa cell tumors. J Clin Endocrinol Metab 2005;90:6529-35.
20. Walhout AJ, Gubbels JM, Bernards R, van der Vliet PC, Timmers HT. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res 1997;25:1493-501.
21. Zeller KI, Zhao X, Lee CWH, Chiu KP, Yao F, Yustein JT, et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A 2006;103:17834-9.
22. Mazaud Guittot S, T-etu A, Legault E, Pilon N, Silversides DW, Viger RS. The proximal Gata4 promoter directs reporter gene expression to sertoli cells during mouse gonadal development. Biol Reprod 2007;76: 85-95.
23. Boulende Sab A, Bouchard M-F, Beland M, Prud'homme B, Souchkova O, Viger RS, et al. An ebox element in the proximal gata4 promoter is required for gata4 expression in vivo. PLoS One 2011;6:e29038.
24. Lyabin DN, Eliseeva IA, Skabkina OV, Ovchinnikov LP. Interplay between Y-box-binding protein 1 (YB-1) and poly(A) binding protein (PABP) in specific regulation of YB-1mRNAtranslation.RNABiol 2011; 8:883-92.
25. WuY, Yamada S, Izumi H, Li Z, Shimajiri S, Wang K-Y, et al. Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer. J Surg Oncol 2012;105:724-30.
26. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, et al. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 2004;10:7917-24.
27. Montavon C, Gloss BS, Warton K, Barton CA, Statham AL, Scurry JP, et al. Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecol Oncol 2012; 124:582-588.
28. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007;8:286-98.
29. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002;298:1039-43.
30. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 2002;16:2893-905.
31. Ptashne M. Regulation of transcription: From lambda to eukaryotes. Trends Biochem Sci 2005;30:275-9.
32. Chen Y, Jørgensen M, Kolde R, Zhao X, Parker B, Valen E, et al. Prediction of RNA Polymerase II recruitment, elongation and stalling from histone modification data. BMC Genomics 2011;12:544.
33. Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, Piotrowski A, et al. The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response. J Biol Chem 2008;283:12154-65.
34. Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002;117:15-23.
35. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002;12: 996-1006.